{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:28:59Z","timestamp":1793384939799,"version":"4.5.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>The intestinal microbiome plays a primary role in the pathogenesis of neurodegenerative disorders and may provide an opportunity for disease modification. We performed a pilot clinical study looking at the safety of fecal microbiota transplantation (FMT), its effect on the microbiome, and improvement of symptoms in Parkinson's disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a randomized, double-blind placebo-controlled pilot study, wherein orally administered lyophilized FMT product or matching placebo was given to 12 subjects with mild to moderate Parkinson's disease with constipation twice weekly for 12 weeks. Subjects were followed for safety and clinical improvement for 9 additional months (total study duration 12 months).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fecal microbiota transplantation caused non-severe transient upper gastrointestinal symptoms. One subject receiving FMT was diagnosed with unrelated metastatic cancer and was removed from the trial. Beta diversity (taxa) of the microbiome, was similar comparing placebo and FMT groups at baseline, however, for subjects randomized to FMT, it increased significantly at 6 weeks (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008) and 13 weeks (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0008). After treatment with FMT, proportions of selective families within the phylum Firmicutes increased significantly, while proportion of microbiota belonging to Proteobacteria were significantly reduced. Objective motor findings showed only temporary improvement while subjective symptom improvements were reported compared to baseline in the group receiving FMT. Constipation, gut transient times (NS), and gut motility index (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0374) were improved in the FMT group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Subjects with Parkinson's disease tolerated multi-dose-FMT, and experienced increased diversity of the intestinal microbiome that was associated with reduction in constipation and improved gut transit and intestinal motility. Fecal microbiota transplantation administration improved subjective motor and non-motor symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>ClinicalTrial.gov<\/jats:ext-link>\n                      , identifier: NCT03671785.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2023.1104759","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:46:13Z","timestamp":1677717973000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":157,"title":["Fecal microbiota transplantation in Parkinson's disease\u2014A randomized repeat-dose, placebo-controlled clinical pilot study"],"prefix":"10.3389","volume":"14","author":[{"given":"Herbert L.","family":"DuPont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessika","family":"Suescun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Dong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather T.","family":"Essigmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"DuPont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tehseen","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netanya S.","family":"Utay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Newmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mya C.","family":"Schiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging."},{"key":"B2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1101\/691030","article-title":"Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions","volume":"18","author":"Baldini","year":"2020","journal-title":"BMC Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","article-title":"Gut microbiota in Parkinson's disease: temporal stability and relations to disease progression","volume":"44","author":"Aho","year":"2019","journal-title":"EBioMedicine."},{"key":"B4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4\/TNF-alpha signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav Immun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s11064-021-03411-0","article-title":"Fecal microbiota transplantation exerts a protective role in MPTP-induced Parkinson's disease via the TLR4\/PI3K\/AKT\/NF-\u03baB pathway stimulated by \u03b1-synuclein","volume":"46","author":"Zhong","year":"2021","journal-title":"Neurochem Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10620-020-06102-y","article-title":"Abnormal intestinal microbiome in medical disorders and potential reversibility by fecal microbiota transplantation","volume":"65","author":"DuPont","year":"2020","journal-title":"Dig Dis Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2014.10.026","article-title":"Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale","volume":"21","author":"Martinez-Martin","year":"2015","journal-title":"Parkinsonism Relat Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/mds.26354","article-title":"Disease-modifying strategies for Parkinson's disease","volume":"30","author":"Kalia","year":"2015","journal-title":"Mov Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mds.870070103","article-title":"Core assessment program for intracerebral transplantations (CAPIT)","volume":"7","author":"Langston","year":"1992","journal-title":"Mov Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0205064","DOI":"10.1371\/journal.pone.0205064","article-title":"Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: a randomized clinical trial","volume":"13","author":"Jiang","year":"2018","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/mds.25919","article-title":"The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale","volume":"29","author":"Leentjens","year":"2014","journal-title":"Mov Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","article-title":"The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score","volume":"26","author":"Jenkinson","year":"1997","journal-title":"Age Ageing."},{"key":"B18","first-page":"214","article-title":"Evaluation of non-motor symptoms in Parkinson's Disease: an underestimated necessity","volume":"17","author":"Bostantjopoulou","year":"2013","journal-title":"Hippokratia."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41531-017-0039-8","article-title":"Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the University of Pennsylvania Smell Identification Test","volume":"4","author":"Morley","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/mds.10248","article-title":"Systematic evaluation of rating scales for impairment and disability in Parkinson's disease","volume":"17","author":"Ramaker","year":"2002","journal-title":"Mov Disord."},{"key":"B21","article-title":"Projection technique for evaluating surgery in Parkinson's disease","volume-title":"Third Symposium on Parkinson's Disease:","author":"Schwab","year":"1969"},{"key":"B22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/mds.25037","article-title":"A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s43441-022-00376-2","article-title":"Measurement comparability of electronic and paper administration of visual analogue scales: a review of published studies","volume":"56","author":"Byrom","year":"2022","journal-title":"Ther Innov Regul Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0126685","DOI":"10.1371\/journal.pone.0126685","article-title":"The effect of sampling and storage on the fecal microbiota composition in healthy and diseased subjects","volume":"10","author":"Tedjo","year":"2015","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e00301","DOI":"10.1128\/IAI.00301-20","article-title":"Impact of diabetes on the gut and salivary IgA microbiomes","volume":"88","author":"Brown","year":"2020","journal-title":"Infect Immun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods."},{"key":"B27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nmeth.2066","article-title":"Metagenomic microbial community profiling using unique clade-specific marker genes","volume":"9","author":"Segata","year":"2012","journal-title":"Nat Methods."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e011014","DOI":"10.1136\/bmjopen-2015-011014","article-title":"SmartPill(R) as an objective parameter for determination of severity and duration of postoperative ileus: study protocol of a prospective, two-arm, open-label trial (the PIDuSA study)","volume":"6","author":"Vilz","year":"2016","journal-title":"BMJ Open."},{"key":"B29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1756283X12437874","article-title":"Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice","volume":"5","author":"Tran","year":"2012","journal-title":"Ther Adv Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/2050640613510161","article-title":"Gastrointestinal motility revisited: the wireless motility capsule","volume":"1","author":"Farmer","year":"2013","journal-title":"Unit Eur Gastroenterol J."},{"key":"B31","volume-title":"Practical Sampling Techniques. 2nd ed","author":"Som","year":"1996"},{"key":"B32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12934-021-01589-0","article-title":"Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation","volume":"20","author":"Kuai","year":"2021","journal-title":"Microb Cell Fact."},{"key":"B33","doi-asserted-by":"publisher","first-page":"106791","DOI":"10.1016\/j.clineuro.2021.106791","article-title":"Fecal microbiota transplant as a potential treatment for Parkinson's disease - a case series","volume":"207","author":"Segal","year":"2021","journal-title":"Clin Neurol Neurosurg."},{"key":"B34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/mds.21894","article-title":"Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord."},{"key":"B35","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update","volume":"46","author":"Afgan","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e029208","DOI":"10.1136\/bmjopen-2019-029208","article-title":"Using the Many-Facet Rasch Model to analyse and evaluate the quality of objective structured clinical examination: a non-experimental cross-sectional design","volume":"9","author":"Tavakol","year":"2019","journal-title":"BMJ Open."},{"key":"B38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.parkreldis.2020.10.034","article-title":"Altered gut microbiota in Parkinson's disease patients\/healthy spouses and its association with clinical features","volume":"81","author":"Zhang","year":"2020","journal-title":"Parkinsonism Relat Disord."},{"key":"B39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnmol.2019.00171","article-title":"Gut microbiota differs between Parkinson's disease patients and healthy controls in Northeast China","volume":"12","author":"Li","year":"2019","journal-title":"Front Mol Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/awab156","article-title":"The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options","volume":"144","author":"Wang","year":"2021","journal-title":"Brain."},{"key":"B41","doi-asserted-by":"publisher","first-page":"840245","DOI":"10.3389\/fimmu.2022.840245","article-title":"Lactobacillus spp. for gastrointestinal health: current and future perspectives","volume":"13","author":"Dempsey","year":"2022","journal-title":"Front Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1053\/j.gastro.2020.10.066","article-title":"The microbiota-gut-brain axis: from motility to mood","volume":"160","author":"Margolis","year":"2021","journal-title":"Gastroenterology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/00365521.1997.11720720","article-title":"Effects of short-chain fatty acids on gastrointestinal motility","volume":"222","author":"Cherbut","year":"1997","journal-title":"Scand J Gastroenterol Suppl."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0147210","DOI":"10.1371\/journal.pone.0147210","article-title":"Changes in colonic bile acid composition following fecal microbiota transplantation are sufficient to control Clostridium difficile germination and growth","volume":"11","author":"Weingarden","year":"2016","journal-title":"PLoS ONE"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1186\/s40064-016-2821-1","article-title":"Intestinal microbiota and chronic constipation","volume":"5","author":"Zhao","year":"2016","journal-title":"Springerplus."},{"key":"B46","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1038\/s41467-022-34667-x","article-title":"Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms","volume":"13","author":"Wallen","year":"2022","journal-title":"Nat Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0260451","DOI":"10.1371\/journal.pone.0260451","article-title":"Intestinal Collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate","volume":"16","author":"Hirayama","year":"2021","journal-title":"PLoS ONE."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0219489","DOI":"10.1371\/journal.pone.0219489","article-title":"A structured weight loss program increases gut microbiota phylogenetic diversity and reduces levels of Collinsella in obese type 2 diabetics: a pilot study","volume":"14","author":"Frost","year":"2019","journal-title":"PLoS ONE."},{"key":"B49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2017.1406584","article-title":"Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women","volume":"9","author":"Gomez-Arango","year":"2018","journal-title":"Gut Microbes."},{"key":"B50","doi-asserted-by":"publisher","first-page":"G368","DOI":"10.1152\/ajpgi.2001.280.3.G368","article-title":"Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats","volume":"280","author":"Husebye","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/cas.14298","article-title":"Significance of the gut microbiome in multistep colorectal carcinogenesis","volume":"111","author":"Mizutani","year":"2020","journal-title":"Cancer Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/jclinpath-2015-202976","article-title":"Mechanisms and therapeutic effectiveness of Lactobacilli","volume":"69","author":"Di Cerbo","year":"2016","journal-title":"J Clin Pathol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000342079","article-title":"Probiotic mechanisms of action","volume":"61","author":"Bermudez-Brito","year":"2012","journal-title":"Ann Nutr Metab."},{"key":"B54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/biom11020144","article-title":"Clinical phenotypes of Parkinson's disease associate with distinct gut microbiota and metabolome enterotypes","volume":"11","author":"Vascellari","year":"2021","journal-title":"Biomolecules"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9351507","DOI":"10.1155\/2017\/9351507","article-title":"Proteobacteria: a common factor in human diseases","volume":"2017","author":"Rizzatti","year":"2017","journal-title":"Biomed Res Int."},{"key":"B56","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","article-title":"Proteobacteria: microbial signature of dysbiosis in gut microbiota","volume":"33","author":"Shin","year":"2015","journal-title":"Trends Biotechnol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","article-title":"Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms","volume":"260","author":"Cersosimo","year":"2013","journal-title":"J Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","article-title":"Medical records documentation of constipation preceding Parkinson disease: a case-control study","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology."},{"key":"B59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.14802\/jmd.18067","article-title":"Altered gut microbiome and intestinal pathology in Parkinson's disease","volume":"12","author":"Chiang","year":"2019","journal-title":"J Mov Disord."},{"key":"B60","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1152\/physiolgenomics.00082.2014","article-title":"Structural changes in the gut microbiome of constipated patients","volume":"46","author":"Zhu","year":"2014","journal-title":"Physiol Genomics."},{"key":"B61","doi-asserted-by":"publisher","first-page":"419","DOI":"10.5217\/ir.2018.00149","article-title":"Is stool frequency associated with the richness and community composition of gut microbiota?","volume":"17","author":"Kwon","year":"2019","journal-title":"Intest Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0016-5085(98)70155-6","article-title":"Measurement of gastrointestinal motility in the GI laboratory","volume":"115","author":"Camilleri","year":"1998","journal-title":"Gastroenterology."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1212\/WNL.0000000000009858","article-title":"BCI training to move a virtual hand reduces phantom limb pain: a randomized crossover trial","volume":"95","author":"Yanagisawa","year":"2020","journal-title":"Neurology."},{"key":"B64","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.sleep.2012.10.023","article-title":"The Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for assessing sleep-related quality of life impairment in insomnia disorder","volume":"14","author":"Kyle","year":"2013","journal-title":"Sleep Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3758\/s13428-018-1041-8","article-title":"The Visual Analogue Scale for Rating, Ranking and Paired-Comparison (VAS-RRP): a new technique for psychological measurement","volume":"50","author":"Sung","year":"2018","journal-title":"Behav Res Methods."},{"key":"B66","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.parkreldis.2020.09.024","article-title":"Unmet needs in Parkinson disease: motor and non-motor","volume":"80","author":"LeWitt","year":"2020","journal-title":"Parkinsonism Relat Disord."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0187307","DOI":"10.1371\/journal.pone.0187307","article-title":"Progression of Parkinson's disease is associated with gut dysbiosis: two-year follow-up study","volume":"12","author":"Minato","year":"2017","journal-title":"PLoS ONE."},{"key":"B68","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov Disord."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1104759\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:46:17Z","timestamp":1677717977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1104759\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":68,"alternative-id":["10.3389\/fneur.2023.1104759"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1104759","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"article-number":"1104759"}}